Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-09 5:00 pm Purchase | 2022-06-24 | 13D | BioAtla, Inc. BCAB | Soleus Private Equity Fund I L.P. | 4,220,397 9.200% | 1,972,873 (+87.78%) | Filing History |
| 2022-06-10 11:04 am Sale | 2022-06-09 | 13G | BioAtla, Inc. BCAB | FMR LLC | 315,211 0.877% | -3,605,461 (-91.96%) | Filing History |
| 2022-04-28 4:00 pm Purchase | 2022-04-18 | 13G | BioAtla, Inc. BCAB | TANG CAPITAL PARTNERS LP | 2,288,900 6.400% | 2,288,900 (New Position) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | BioAtla, Inc. BCAB | SHORT JAY M PHD | 2,701,327 7.540% | 2,701,327 (New Position) | Filing History |
| 2022-02-14 3:07 pm Sale | 2021-12-31 | 13G | BioAtla, Inc. BCAB | Cormorant Asset Management LP | 2,038,215 5.770% | -253,845 (-11.07%) | Filing History |
| 2022-02-11 4:55 pm Sale | 2021-12-31 | 13G | BioAtla, Inc. BCAB | PFIZER INC PFE | 1,372,052 3.880% | -866,038 (-38.70%) | Filing History |
| 2022-02-11 4:04 pm Sale | 2021-12-31 | 13G | BioAtla, Inc. BCAB | HBM Healthcare Investments (Cayman) Ltd. | 1,427,317 4.000% | -1,263,552 (-46.96%) | Filing History |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | BioAtla, Inc. BCAB | The Vanguard Group | 2,264,654 6.410% | 2,264,654 (New Position) | Filing History |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | BioAtla, Inc. BCAB | FMR LLC | 3,920,672 11.092% | -156,919 (-3.85%) | Filing History |
| 2022-02-08 11:52 am Unchanged | 2021-12-31 | 13G | BioAtla, Inc. BCAB | FARALLON CAPITAL MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-04 09:15 am Purchase | 2021-12-31 | 13G | BioAtla, Inc. BCAB | Wellington Management Group LLP | 3,232,480 9.150% | 3,232,480 (New Position) | Filing History |
| 2021-09-03 5:16 pm Sale | 2021-08-24 | 13D | BioAtla, Inc. BCAB | Soleus Private Equity Fund I L.P. | 2,247,524 6.950% | -546,709 (-19.57%) | Filing History |
| 2021-06-28 4:32 pm Sale | 2021-06-17 | 13D | BioAtla, Inc. BCAB | Soleus Private Equity Fund I L.P. | 2,794,233 8.690% | -400,000 (-12.52%) | Filing History |
| 2021-04-12 1:05 pm Purchase | 2021-04-09 | 13G | BioAtla, Inc. BCAB | FMR LLC | 4,077,591 12.674% | 2,297,505 (+129.07%) | Filing History |
| 2021-02-16 4:19 pm Purchase | 2021-02-16 | 13G | BioAtla, Inc. BCAB | Himalaya Parent LLC | 8,682,304 26.990% | 8,682,304 (New Position) | Filing History |
| 2021-02-16 3:16 pm Unchanged | 2020-12-31 | 13G | BioAtla, Inc. BCAB | Cormorant Asset Management LP | 2,292,060 7.120% | 0 (Unchanged) | Filing History |
| 2021-02-12 6:00 pm Purchase | 2020-12-31 | 13G | BioAtla, Inc. BCAB | PFIZER INC PFE | 2,238,090 7.000% | 2,238,090 (New Position) | Filing History |
| 2021-02-08 10:17 am Purchase | 2021-02-05 | 13G | BioAtla, Inc. BCAB | FMR LLC | 1,780,086 5.533% | 1,780,086 (New Position) | Filing History |
| 2020-12-28 4:30 pm Purchase | 2020-12-15 | 13D | BioAtla, Inc. BCAB | Soleus Private Equity Fund I L.P. | 3,194,233 9.930% | 3,194,233 (New Position) | Filing History |
| 2020-12-28 4:06 pm Purchase | 2020-12-15 | 13G | BioAtla, Inc. BCAB | HBM Healthcare Investments (Cayman) Ltd. | 2,690,869 8.800% | 2,690,869 (New Position) | Filing History |